Capricor Therapeutics Inc

NASDAQ:CAPR   4:00:00 PM EDT
6.79
+0.02 (+0.30%)
4:55:53 PM EDT: $6.65 -0.14 (-2.06%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)213.21M
Current PEN/A
Forward PE N/A
2yr Forward PE 67.9
See more stats
Estimates Current Quarter
Revenue$9.7 Million
Adjusted EPS-$0.11
See more estimates
10-Day MA$6.50
50-Day MA$4.81
200-Day MA$4.59
See more pivots

Capricor Therapeutics Inc Stock, NASDAQ:CAPR

10865 Road to the Cure, Suite 150, San Diego, California 92121
United States of America
Phone: +1.858.727.1755
Number of Employees: 102

Description

Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.